CAPTRUST Financial Advisors
KRRO icon

CAPTRUST Financial Advisors’s Korro Bio KRRO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-190
Closed -$14K – 3124
2022
Q2 		$14K Hold
190
– – ﹤0.01% 3568
2022
Q1 		$20K Hold
190
– – ﹤0.01% 3386
2021
Q4 		$49K Hold
190
– – ﹤0.01% 2688
2021
Q3 		$67K Hold
190
– – ﹤0.01% 2378
2021
Q2 		$95K Sell
190
-976
-84% -$477K ﹤0.01% 2073
2021
Q1 		$554K Sell
1,166
-501
-30% -$973K 0.01% 925
2020
Q4 		$2.94M Buy
+1,667
New +$2.2M 0.04% 334

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

CAPTRUST Financial Advisors's KRRO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Korro Bio (KRRO) in Q3 2022, closing a stake of 190 shares — an estimated $14K sold.

CAPTRUST Financial Advisors first reported a position in KRRO in Q4 2020 and held it in 7 quarters. The position peaked at $2.94M in Q4 2020. 55 funds tracked by Wall St. Rank hold KRRO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Korro Bio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 190 Korro Bio shares in Q3 2022, an estimated $14K.
  • CAPTRUST Financial Advisors first reported a position in Korro Bio in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Korro Bio position peaked at $2.94M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Korro Bio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.